Randomised placebo-controlled waiting list experimental medicine study. Participants will be randomised 1:1 to either im clinical trials

Evaluating the role of IL-17 as an orchestrator of peripheral-central cross talk in depressive symptoms

This study looks at how a medicine blocking IL-17, used for skin and joint conditions, might help improve depression in people with these conditions. It uses brain scans to see if reducing inflammation in the body also affects the brain and mood.